144 related articles for article (PubMed ID: 6203132)
21. Antitumour effects of pure diastereoisomers of 5-formyltetrahydrofolate in hepatic transplants of a rodent colon carcinoma model.
Carlsson G; Gustavsson B; Frösing R; Odin E; Hafström LO; Spears CP; Larsson PA
Biochem Pharmacol; 1995 Oct; 50(9):1347-51. PubMed ID: 7503782
[TBL] [Abstract][Full Text] [Related]
22. In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas.
Spears CP; Shahinian AH; Moran RG; Heidelberger C; Corbett TH
Cancer Res; 1982 Feb; 42(2):450-6. PubMed ID: 6173112
[TBL] [Abstract][Full Text] [Related]
23. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R
Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
[TBL] [Abstract][Full Text] [Related]
24. Cellular pharmacology of 5-fluorouracil in a human colon adenocarcinoma cell line selected for thymidine kinase deficiency.
Radparvar S; Houghton PJ; Germain G; Pennington J; Rahman A; Houghton JA
Biochem Pharmacol; 1990 Jun; 39(11):1759-65. PubMed ID: 2344373
[TBL] [Abstract][Full Text] [Related]
25. Effects of thymidine and thymidine plus 5-fluorouracil on the growth kinetics of a human lymphoid cell line.
Murgo AJ; Fried J; Burchenal D; Vale KL; Strife A; Woodcock T; Young CW; Clarkson BD
Cancer Res; 1980 May; 40(5):1543-9. PubMed ID: 6445227
[No Abstract] [Full Text] [Related]
26. [Molecular biological analysis of 5-fluorouracil sensitivity in colorectal neoplasm].
Kubota T; Yoshinare K; Kabeshima Y; Watanabe M; Kitajima M
Nihon Rinsho; 2003 Sep; 61 Suppl 7():321-4. PubMed ID: 14574903
[No Abstract] [Full Text] [Related]
27. Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.
Grem JL; Danenberg KD; Behan K; Parr A; Young L; Danenberg PV; Nguyen D; Drake J; Monks A; Allegra CJ
Clin Cancer Res; 2001 Apr; 7(4):999-1009. PubMed ID: 11309351
[TBL] [Abstract][Full Text] [Related]
28. [Factors of the therapeutic effectiveness of 5-fluorouracil].
Manziuk LV; Donenko FV; Sitdikova SM; Moroz LV
Vopr Onkol; 1996; 42(2):31-6. PubMed ID: 8815630
[No Abstract] [Full Text] [Related]
29. Cell-cycle distribution and Thymidilate Synthatase (TS) expression correlate with 5-FU resistance in head and neck carcinoma cells.
Ijichi K; Adachi M; Ogawa T; Hasegawa Y; Murakami S
Anticancer Res; 2014 Jun; 34(6):2907-11. PubMed ID: 24922653
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of thymidylate synthase mediates desensitization for 5-fluorouracil of tumor cells.
Saga Y; Suzuki M; Mizukami H; Kohno T; Takei Y; Fukushima M; Ozawa K
Int J Cancer; 2003 Sep; 106(3):324-6. PubMed ID: 12845668
[TBL] [Abstract][Full Text] [Related]
31. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
[TBL] [Abstract][Full Text] [Related]
32. Use of antimetabolites in the study of normal and abnormal cell structure and function.
Love R; Studzinski GP; Ellem KA
Fed Proc; 1965; 24(5):1206-16. PubMed ID: 4220917
[No Abstract] [Full Text] [Related]
33. Biochemical and pharmacologic basis for potentiation of 5-fluorouracil action by leucovorin.
Rustum YM; Trave F; Zakrzewski SF; Petrelli N; Herrera L; Mittelman A; Arbuck SG; Creaven PJ
NCI Monogr; 1987; (5):165-70. PubMed ID: 2448653
[TBL] [Abstract][Full Text] [Related]
34. Resistance to 5-fluorouracil.
Mader RM; Müller M; Steger GG
Gen Pharmacol; 1998 Nov; 31(5):661-6. PubMed ID: 9809460
[TBL] [Abstract][Full Text] [Related]
35. Comparative effects of ftorafur and 5-fluorouracil on DNA synthesis in rat small intestine.
Cohen AM
Life Sci; 1975 Nov; 17(9):1363-7. PubMed ID: 1207401
[No Abstract] [Full Text] [Related]
36. Mechanisms of clinical resistance to 5-fluorouracil chemotherapy.
Chu E; Allegra CJ
Cancer Treat Res; 1996; 87():175-95. PubMed ID: 8886453
[No Abstract] [Full Text] [Related]
37. Effect of 5-fluorouracil on RNA metabolism in Novikoff hepatoma cells.
Cory JG; Breland JC; Carter GL
Cancer Res; 1979 Dec; 39(12):4905-13. PubMed ID: 498116
[TBL] [Abstract][Full Text] [Related]
38. Enhanced antitumor activity of 5-fluorouracil in combination with 2'-deoxyinosine in human colorectal cell lines and human colon tumor xenografts.
Ciccolini J; Peillard L; Evrard A; Cuq P; Aubert C; Pelegrin A; Formento P; Milano G; Catalin J
Clin Cancer Res; 2000 Apr; 6(4):1529-35. PubMed ID: 10778986
[TBL] [Abstract][Full Text] [Related]
39. The pharmacology of the fluoropyrimidines.
Myers CE
Pharmacol Rev; 1981 Mar; 33(1):1-15. PubMed ID: 6170079
[No Abstract] [Full Text] [Related]
40. Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to fluorodeoxyuridine.
Zhang ZG; Malmberg M; Yin MB; Slocum HK; Rustum YM
Biochem Pharmacol; 1993 Mar; 45(5):1157-64. PubMed ID: 8461045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
